The use of quantitative real-time polymerase chain reaction (qRT-PCR) to test for BCR-ABL1 transcript levels in chronic myeloid leukemia (CML) is t......READ MORE
For some—but not all—patients with chronic myeloid leukemia (CML), tyrosine kinase inhibitor (TKI) therapy produces deep remissions with immune res......READ MORE
Tyrosine kinase inhibitors (TKIs) have revolutionized the treatment of chronic myeloid leukemia (CML) to such an extent that this once-lethal disea......READ MORE
Although upfront testing with next-generation sequencing (NGS) for BCR-ABL1 kinase domain mutations is not currently standard, the science of mutat......READ MORE